These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 34585166

  • 21. Overexpression of follistatin-like 3 in gonads causes defects in gonadal development and function in transgenic mice.
    Xia Y, Sidis Y, Schneyer A.
    Mol Endocrinol; 2004 Apr; 18(4):979-94. PubMed ID: 14739256
    [Abstract] [Full Text] [Related]

  • 22. Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis.
    Amthor H, Nicholas G, McKinnell I, Kemp CF, Sharma M, Kambadur R, Patel K.
    Dev Biol; 2004 Jun 01; 270(1):19-30. PubMed ID: 15136138
    [Abstract] [Full Text] [Related]

  • 23. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice.
    Nakatani M, Takehara Y, Sugino H, Matsumoto M, Hashimoto O, Hasegawa Y, Murakami T, Uezumi A, Takeda S, Noji S, Sunada Y, Tsuchida K.
    FASEB J; 2008 Feb 01; 22(2):477-87. PubMed ID: 17893249
    [Abstract] [Full Text] [Related]

  • 24. Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice.
    Allen DL, Cleary AS, Speaker KJ, Lindsay SF, Uyenishi J, Reed JM, Madden MC, Mehan RS.
    Am J Physiol Endocrinol Metab; 2008 May 01; 294(5):E918-27. PubMed ID: 18334608
    [Abstract] [Full Text] [Related]

  • 25. Inhibiting myostatin with follistatin improves the success of myoblast transplantation in dystrophic mice.
    Benabdallah BF, Bouchentouf M, Rousseau J, Bigey P, Michaud A, Chapdelaine P, Scherman D, Tremblay JP.
    Cell Transplant; 2008 May 01; 17(3):337-50. PubMed ID: 18522236
    [Abstract] [Full Text] [Related]

  • 26. Alterations in activin A-myostatin-follistatin system associate with disease activity in inflammatory myopathies.
    Vernerová L, Horváthová V, Kropáčková T, Vokurková M, Klein M, Tomčík M, Oreská S, Špiritović M, Štorkánová H, Heřmánková B, Kubínová K, Kryštůfková O, Mann H, Ukropec J, Ukropcová B, Vencovský J.
    Rheumatology (Oxford); 2020 Sep 01; 59(9):2491-2501. PubMed ID: 31990347
    [Abstract] [Full Text] [Related]

  • 27. Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia.
    Benny Klimek ME, Aydogdu T, Link MJ, Pons M, Koniaris LG, Zimmers TA.
    Biochem Biophys Res Commun; 2010 Jan 15; 391(3):1548-54. PubMed ID: 20036643
    [Abstract] [Full Text] [Related]

  • 28. Activin A and follistatin-like 3 determine the susceptibility of heart to ischemic injury.
    Oshima Y, Ouchi N, Shimano M, Pimentel DR, Papanicolaou KN, Panse KD, Tsuchida K, Lara-Pezzi E, Lee SJ, Walsh K.
    Circulation; 2009 Oct 20; 120(16):1606-15. PubMed ID: 19805648
    [Abstract] [Full Text] [Related]

  • 29. Novel Roles of Follistatin/Myostatin in Transforming Growth Factor-β Signaling and Adipose Browning: Potential for Therapeutic Intervention in Obesity Related Metabolic Disorders.
    Pervin S, Reddy ST, Singh R.
    Front Endocrinol (Lausanne); 2021 Oct 20; 12():653179. PubMed ID: 33897620
    [Abstract] [Full Text] [Related]

  • 30. Hypoxia enhances the expression of follistatin-like 3 in term human trophoblasts.
    Biron-Shental T, Schaiff WT, Rimon E, Shim TL, Nelson DM, Sadovsky Y.
    Placenta; 2008 Jan 20; 29(1):51-7. PubMed ID: 17959243
    [Abstract] [Full Text] [Related]

  • 31. Regulation of follistatin-like 3 expression by miR-486-5p modulates gastric cancer cell proliferation, migration and tumor progression.
    Dai ZT, Xiang Y, Zhang XY, Zong QB, Wu QF, Huang Y, Shen C, Li JP, Ponnambalam S, Liao XH.
    Aging (Albany NY); 2021 Aug 23; 13(16):20302-20318. PubMed ID: 34425560
    [Abstract] [Full Text] [Related]

  • 32. Local versus systemic control of bone and skeletal muscle mass by components of the transforming growth factor-β signaling pathway.
    Liu Y, Lehar A, Rydzik R, Chandok H, Lee YS, Youngstrom DW, George J, Matzuk MM, Germain-Lee EL, Lee SJ.
    Proc Natl Acad Sci U S A; 2021 Aug 17; 118(33):. PubMed ID: 34385332
    [Abstract] [Full Text] [Related]

  • 33. Follistatin and follistatin-like 3 in metabolic disorders.
    Bielka W, Przezak A, Pawlik A.
    Prostaglandins Other Lipid Mediat; 2023 Dec 17; 169():106785. PubMed ID: 37739334
    [Abstract] [Full Text] [Related]

  • 34. Follistatin-like 3 mediates paracrine fibroblast activation by cardiomyocytes.
    Panse KD, Felkin LE, López-Olañeta MM, Gómez-Salinero J, Villalba M, Muñoz L, Nakamura K, Shimano M, Walsh K, Barton PJ, Rosenthal N, Lara-Pezzi E.
    J Cardiovasc Transl Res; 2012 Dec 17; 5(6):814-26. PubMed ID: 22915069
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Activin Enhances α- to β-Cell Transdifferentiation as a Source For β-Cells In Male FSTL3 Knockout Mice.
    Brown ML, Andrzejewski D, Burnside A, Schneyer AL.
    Endocrinology; 2016 Mar 17; 157(3):1043-54. PubMed ID: 26727106
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.